ArticleCancers2021

SHP2 as a Potential Therapeutic Target in Diffuse-Type Gastric Carcinoma Addicted to Receptor Tyrosine Kinase Signaling.

Yuko Nagamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.